Humana (HUM) Valuation Check As Shares Face Ongoing Medicare Advantage Regulatory Pressure

Simply Wall St.04-02 11:28

AdvertisementEvent context and recent share performance Humana (HUM) has been drawing attention after a rough stretch for the shares, with the stock showing negative returns over the past month, past ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2624352286?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/29618-main-header/1756204961955","is_english":true,"pubTime":"2026-04-02 11:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624352286","market":"nz","top_or_hot":-1,"title":"Humana (HUM) Valuation Check As Shares Face Ongoing Medicare Advantage Regulatory Pressure","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementEvent context and recent share performance Humana (HUM) has been drawing attention after a rough stretch for the shares, with the stock showing negative returns over the past month, past ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-valuation-check-as-shares-face-ongoing-medicare-a\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Humana (HUM) Valuation Check As Shares Face Ongoing Medicare Advantage Regulatory Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHumana (HUM) Valuation Check As Shares Face Ongoing Medicare Advantage Regulatory Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-02 11:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-valuation-check-as-shares-face-ongoing-medicare-a><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementEvent context and recent share performance Humana (HUM) has been drawing attention after a rough stretch for the shares, with the stock showing negative returns over the past month, past ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-valuation-check-as-shares-face-ongoing-medicare-a\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1983260115.SGD","symbol_name":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-valuation-check-as-shares-face-ongoing-medicare-a","article_id":"2624352286","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/29618-main-header/1756204961955"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-valuation-check-as-shares-face-ongoing-medicare-a","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2624352286","pubTimestamp":1775100527,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Event context and recent share performance\nHumana (HUM) has been drawing attention after a rough stretch for the shares, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year.\nSee our latest analysis for Humana.\nAt a share price of $176.95, Humana has seen pressure build over time, with a 30 day share price return of a 5.52% decline and a 1 year total shareholder return of a 32.38% decline, which suggests sentiment has been weakening...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4585":"ETF&股票定投概念","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","BK7500":"支付概念","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","HUM.AU":"HUMM GROUP LTD","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","BK4566":"资本集团","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK7093":"消费信贷","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","HUM":"哈门那","BK4588":"碎股","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4154":"管理型保健护理"},"translate_title":"Humana(HUM)估值检查，股价面临持续的Medicare Advantage监管压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HUM":1,"HUM.AU":1.5},"content_text":"AdvertisementEvent context and recent share performance Humana (HUM) has been drawing attention after a rough stretch for the shares, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Humana. At a share price of $176.95, Humana has seen pressure build over time, with a 30 day share price return of a 5.52% decline and a 1 year total shareholder return of a 32.38% decline, which suggests sentiment has been weakening rather than building momentum. If this shift in market mood has you reassessing your options in healthcare, it could be a good time to see what else is moving with our screen of 33 healthcare AI stocks. With Humana trading at $176.95 alongside mixed recent returns and an indicated discount to some valuation estimates, you have to ask whether the share price now reflects excessive pessimism, or if the market already sees limited future growth potential. Most Popular Narrative: 16.9% Undervalued Humana's widely followed fair value estimate of $212.87 sits comfortably above the last close at $176.95, which puts a clear spotlight on what is driving that gap.  Humana (NYSE: HUM) is navigating a regulatory environment that is becoming increasingly unforgiving. While Medicare Advantage has been a powerful growth engine for insurers over the past decade, recent developments suggest that oversight is intensifying, and the margin for error is shrinking.  Read the complete narrative. The valuation hinges on how Medicare Advantage profitability holds up as rules tighten, how margins evolve from slim current levels, and how future earnings are modeled against that regulatory pressure. Result: Fair Value of $212.87 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this hinges on regulators not tightening Medicare Advantage rules further and on Humana avoiding large audit repayments that could keep pressure on already slim margins. Find out about the key risks to this Humana narrative. Next Steps With sentiment clearly split between concern and opportunity, this is the moment to check the numbers yourself and decide where you stand, starting with 3 key rewards and 2 important warning signs. Looking for more investment ideas? If Humana has you rethinking your next move, broaden your watchlist now so you do not miss other opportunities lining up across different styles of stocks.  Target stability and income by reviewing companies that qualify as 12 dividend fortresses for investors who care about regular cash returns. Hunt for mispriced quality by scanning the 63 high quality undervalued stocks that pair solid fundamentals with appealing valuations. Reduce portfolio stress by focusing on 65 resilient stocks with low risk scores that may offer relatively steadier profiles compared to more volatile names.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Humana might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624352286","isCrawlerRequest":true}